TYK Medicines, Inc (HKG:2410)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.67
-0.31 (-4.38%)
Aug 21, 2026, 4:08 PM HKT

TYK Medicines Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
--0.11-44.24
Revenue Growth
-----
Gross Profit
--0.01-20.04
Operating Income
-352.51-322.54-343.76-308.56-243.31
Net Income
-212.49-299.77-386.96-382.43-310.99
Earnings Per Share
-0.58-0.80-1.15-1.32-1.12
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
201.96367.29460.46192.83243.49
Total Debt
149.63152.81176.8541.7355.95
Net Cash (Debt)
52.33214.47283.62151.1187.54
Net Cash Growth
-75.60%-24.38%87.70%-19.43%-
Net Cash Per Share
0.140.570.840.520.68

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
--215.77-308.25-200.94-220.05
Capital Expenditures
--39.41-73.62-76.38-58.97
Free Cash Flow
--255.18-381.87-277.32-279.02
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
--13.08%-45.30%
Operating Margin
---321274.77%--549.94%
Pretax Margin
---362549.53%--704.76%
Profit Margin
---361640.19%--702.94%
FCF Margin
---356891.59%--630.67%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
--153556.30--